Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) ...

Seegene will present its unmanned PCR automation system 'CURECA™ (Cureka)' and diagnostic data analysis platform 'STAgora™ (Stagora)' at the Society for Diagnostics & Laboratory Medicine (ADLM 2025)' ...

Seegene Inc., a global leader in molecular diagnostics, announced today that it will unveil its fully automated PCR testing ...

Download Free Sample of This Strategic Report with Industry Analysis @ The Saudi Arabia Hospital Clinical Chemistry and Immunodiagnostics Market presents a dynamic landscape shaped by evolving ...

Seegene introduces end-to-end automation in PCR diagnostics and a real-time global data platform to support clinical decision ...

The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various ...

Upgrades to software on Bionano’s Stratys™ Compute, a server that leverages advanced GPU chips, double the number of cancer samples that can be analyzed per week and expand functionality to include ...

Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved ...

(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of NEO PanTracer™ LBx, a blood-based comprehensive genomic profiling (CGP) ...

Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling. Comprehensive ...

In this video interview, Michael Miller, chief operating officer at Quanterix, outlines key technical and regulatory ...

Discover how AVA brings scale and reproducibility to organ‑chip technology, enabling human‑relevant insights that accelerate ...